Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study.

Lång K, Josefsson V, Larsson A-M, et al. Lancet Oncol. 2023;24(8):936-944. Retrospective studies have shown artificial intelligence (AI) to be at least as accurate as radiologists in detecting breast cancer in screening mammograms. This prospective randomized trial similarly demonstrated that AI readings were as accurate as double readings by radiologists, but with a significantly reduced workload. https://psnet.ahrq.gov/issue/artificial-intelligence-supported-screen-reading-versus-standard-double-reading-mammography